Buying a GLP-1 from a Canadian or overseas pharmacy

What the FDA actually publishes

This subject is usually discussed in terms of what people get away with. It is more useful to read what the agency says, because the conditions are published and specific. The general rule first:

In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S.

The FDA then sets out when it may consider a more permissive decision. The wording matters: this is a description of when the agency might decline to act, not a category of lawful import. The conditions, for a product treating a serious condition, are these.

1. 01

   For a serious condition with no effective domestic treatment

   The product is for a serious condition for which effective treatment may not be available domestically.

2. 02

   Not promoted to people in the US

   There is no known commercialisation or promotion of the product to persons residing in the United States.

3. 03

   Not an unreasonable risk

   The product does not represent an unreasonable risk.

4. 04

   Affirmed in writing, and limited in quantity

   The consumer affirms in writing that it is for personal use, and the quantity is generally not more than a three-month supply.

Why GLP-1s fail two of them

Most discussion of importing focuses on the third and fourth conditions — is it risky, how much can I bring. For GLP-1 medications the argument ends earlier than that, because the first two are not satisfied.

Effective treatment is available domestically. That is the plain situation: several manufacturers sell FDA-approved GLP-1 products in the United States, in injection and tablet form, and the approved products each have a US label setting out what they are and who they are for. The condition contemplates a drug you cannot get here. These are drugs you can get here.

And the advertising is itself disqualifying. This is the part worth sitting with. The condition rules out a product being commercialised or promoted to people living in the US — so a pharmacy running ads at American customers, quoting savings against American prices, is describing itself out of the policy. The sites most visible to someone searching this question are the ones the condition most clearly excludes, and the visibility is the reason.

The pharmacies advertising to Americans are, by advertising to Americans, outside the policy that would have made importing tolerable.

The saving is measured against the wrong number

Overseas quotes are usually contrasted with a US list price, which almost nobody pays. The honest comparison is against what you could actually pay here, and the published self-pay floor for an FDA-approved GLP-1 is currently $149 a month — matched by Wegovy, Foundayo and Ozempic. Set beside that, a good deal of the advertised advantage is arithmetic against a figure the seller chose.

The routes that actually cost less are unglamorous and domestic: manufacturer self-pay pricing, a savings card if you have commercial insurance, and the Medicare Bridge programme if you are eligible for it. All three are priced, dated and sourced in the comparison of every route, and the cheapest of them requires no customs risk and no guess about what is in the vial.

Bringing medication back from a trip is a different question

The FDA guidance does contemplate continuing a treatment begun abroad: a product for the continuation of treatment started in another country, generally not more than a three-month supply, with the person affirming in writing that it is for their own use and providing contact details for the doctor treating them.

That describes someone returning home mid-treatment. It does not describe ordering from a website that ships to the United States, and the two get conflated constantly — usually by people selling the second while describing the first.

Common questions

Is it legal to buy a GLP-1 from a Canadian pharmacy?

In most circumstances, no. The FDA states plainly that it is illegal for individuals to import drugs into the US for personal use, because products bought from other countries often have not been approved by the FDA for sale here. There is a narrow policy under which the agency may decline to act, but it is enforcement discretion rather than permission, and GLP-1s do not meet its conditions.

Why do GLP-1s fail the FDA's personal importation conditions?

Two of the conditions fail at once. The policy contemplates a product for a serious condition for which effective treatment may not be available domestically — GLP-1s are available domestically, from several manufacturers, in multiple forms. And it requires that there be no known commercialisation or promotion of the product to people living in the US, which a pharmacy advertising savings to American customers fails by the act of advertising.

What about sites advertising 80% savings on Ozempic from Canada?

Advertising to US residents is the specific thing the FDA condition names. A site marketing to Americans is, by doing so, outside the policy it is implicitly relying on. That is separate from the question of whether the product is what it claims to be, which you cannot verify from a website and which no US regulator has checked.

Is a cheaper price overseas worth the risk?

The comparison is usually less favourable than it looks, because the honest alternative is not the US list price. Manufacturer self-pay pricing, savings cards and the Medicare Bridge programme all cost far less than list, and are the prices an overseas quote should be measured against rather than the sticker figure it is usually contrasted with.

Can I bring a GLP-1 back from a trip abroad?

That is a different situation from ordering online, and the FDA's guidance contemplates it — a product for continuation of treatment begun in a foreign country, generally not more than a three-month supply, with the individual affirming in writing that it is for personal use. It remains enforcement discretion rather than a right, and it does not describe a mail-order purchase from a website.

Related reading

The domestic alternatives are set out in every route to a GLP-1, priced side by side. If a membership fee is what you are trying to avoid, two national pharmacy chains now prescribe without one — see what Walgreens and CVS charge for a visit. And the regulatory status of the compounded products often sold alongside these offers is covered in compounded semaglutide.

This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.